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Abstract The purpose of this study was to compare
inter-observer agreement of StratusTM OCT versus
SpectralisTM OCT image grading in patients with
neovascular age-related macular degeneration (AMD).
Thirty eyes with neovascular AMD were examined
with StratusTM OCT and SpectralisTM OCT. Four
different scan protocols were used for imaging. Three
observers graded the images for the presence of various
pathologies. Inter-observer agreement between OCT
models was assessed by calculating intra-class corre-
lation coefficients (ICC). In StratusTM OCT highest
interobserver agreement was found for subretinal fluid
(ICC: 0.79), and in SpectralisTM OCT for intraretinal
cysts (IRC) (ICC: 0.93). SpectralisTM OCT showed
superior interobserver agreement for IRC and epireti-
nal membranes (ERM) (ICCStratusTM: for IRC 0.61; for
ERM 0.56; ICCSpectralisTM: for IRC 0.93; for ERM
0.84). Increased image resolution of SpectralisTM OCT
did improve the inter-observer agreement for grading
intraretinal cysts and epiretinal membranes but not for
other retinal changes.
Keywords Age-related macular degeneration 
Image grading  Optical coherence tomography 
Reproducibility  Retina
Introduction
Optical coherence tomography (OCT) was introduced
in 1991 as a non-invasive, cross sectional imaging
technique [1]. In 1995 Time-Domain OCT (TD-OCT)
was used first for imaging macular diseases with many
studies published about imaging in age-related macular
degeneration (AMD) [2–15]. In neovascular AMD,
retinal structure can be disturbed by choroidal neovas-
cularisation (CNV) which is frequently associated with
intraretinal cysts (IRC), subretinal fluid accumulation
(SRF), pigment epithelium detachments (PED), and
epiretinal membranes (ERM). In addition, one can fre-
quently observe subretinal hyper-reflective material
(SHM) in OCT images that might correspond to sub-
retinal scar tissue, haemorrhages, fibrin formation and
subretinal deposition or choroidal neovascularisations.
Recently, different treatment modalities for neovas-
cular AMD have been introduced [11, 12, 16–19].
Conventional TD-OCT plays an important role in
following patients with neovascular AMD during
therapy with intravitreal anti-VEGF agents such as
ranibizumab or bevacizumab [16]. OCT imaging was
part of main outcome measures in various clinical trials.
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This led to the creation of OCT reading centers where
independent observers review OCT scans for defined
pathologies and retinal thickness measurements. Data
regarding OCT retinal thickness measurement repro-
ducibility has been published previously [20–27].
Recently, improvements in OCT technology have
been introduced [28, 29]. Spectral-Domain OCT
(SD-OCT) provides increased resolution and scanning
speed by recording the interferometric information
using a Fourier-domain-spectrometric method. Axial
resolution is up to five microns and imaging speed is
up to 100 times faster than in conventional TD-OCT
[30, 31]. In addition to radial line scans (RLS),
SD-OCT can perform high-density volume scans
(VS). These volume scans provide considerably more
data compared to the six radial line scans of conven-
tional TD-OCT and allow calculation of a three-
dimensional map of the macula with less need for
interpolation within the scanning area. Some SD-OCT
devices offer averaging of multiple scan images for
noise reduction and in addition a real time eye tracking
for improved reproducibility of measurements. SD-
OCT has been used previously to demonstrate its
ability to visualize macular pathologies in patients
with AMD [32–36].
One can hypothesize that higher scan resolution and
greater scan coverage, i.e. higher number of B-scans,
might lead to increased identification of retinal lesions
in AMD and a higher interpretation agreement between
different clinicians (inter-observer agreement).
Our goal was to compare the result of TD-OCT with
SD-OCT in terms of grading-agreements between
three independent observers. Two scan types in each
OCT device were used.
Methods
Thirty eyes of 28 patients with previously diagnosed
neovascular AMD were included in this prospective,
comparative, observational study. Exclusion criteria
were patients with severe media opacity, patients
unable to undergo OCT examination, and patients
with vast central subretinal hemorrhages that make
OCT image interpretation impossible. OCT images
had to be of good quality which was considered if all
single line scans within a scan type showed a good
signal with detailed retinal structure, no blinking
artifacts, and no problems with the retinal thickness
measurement algorithm. The initial diagnosis of exu-
dative AMD was established by fundus examination
and fluorescein angiography. All study patients were
recruited from the retina unit of the Department of
Ophthalmology, University Hospital Zurich, Switzer-
land. All patients had previous anti-VEGF treatments
with either bevacizumab or ranibizumab for their
CNV and were planned for regular follow-up exam-
inations. Study patients gave written informed consent
to participate in this study, which was approved by the
local ethics committee.
For OCT, StratusTM OCT (Zeiss Meditec, Dublin,
CA, USA, Softwareversion 4.0.7) was used for Fast
Macular scan (FMS) and Cross Hair scan (CHS). FMS
consists of 6 intersecting line scans in a spoke wheel-
like pattern. Each line is 6 mm long and includes 128
A-scans. The CHS consists of two intersecting line
scans of 6 mm length in a cross pattern. Each line scan
includes 512 A-scans. Both scan protocols were
chosen, because they belong to the most common
used protocols in clinical routine and in ongoing
clinical trials. SpectralisTM OCT (Heidelberg Engi-
neering, Heidelberg, Germany, Softwareversion 5.3)
was used to perform high-resolution volume scans
(VS), and radial line scans (RLS). For the VS, a raster
scan pattern consisting of 25 line scans was chosen for
macular scanning in an area of 30 9 20. Each line
scan was averaged 25-times by the SpectralisTM OCT
ART function. The SpectralisTM OCT is capable of
performing more line scans per raster scan for even
greater retinal coverage. However, since patients with
AMD are rather old and visual acuity and fixation
stability is relatively poor, scan numbers were reduced
to 25 line scans in order to speed up the scanning
process and to allow measurements in less than 3 min.
The RLS consists of 6 intersecting line scans similar to
the FMS of StratusTM OCT with 512 A-scan per line
and a scan length of 20. Figure 1 shows examples of
all 4 OCT scan types.
Three observers (PBK, HK, MNM) reviewed the
OCT scans of all study eyes independently. All
observers were specialist for treating exudative AMD
and experienced OCT user, but not specifically trained
grader from an OCT reading center. All 120 scans (30
eyes 9 4 scan types) were presented in random order.
Since the 4 scan types consisted of 6 (FMS), 2 (CHS), 6
(RLS), and 25 (VS) single line scans, a total of 1,170
single line scans were reviewed. Each observer was
masked to the patient data and to the decision of the
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treating physician regarding re-treatment with intravi-
treal anti-VEGF drugs. Images were presented on a
high resolution monitor.
Observers were asked to review each line scan
within the scan protocol (FMS, CHS, VS, and RLS)
and to give a summarized grading for each scan and
eye for the absence (=0) or presence (=1) of IRC, SRF,
PED, ERM, and SHM.
IRC were defined as the any noticeable presence of
hypo-reflective, round or oval-shaped spaces within
the neurosensory retina. SRF was defined as a hypo-
reflective space between the neurosensory retina and
the retinal pigment epithelium. PED was defined as
any elevation (not just localized thickening of the
retinal pigment epithelium such as in Drusen) of the
retinal pigment epithelium layer with consecutive
elevation of the neurosensory retina. ERM was defined
as a highly-reflective thin layer on top of the inner
limiting membrane with or without retinal wrinkling.
SHM was defined as a highly-reflective signal under-
neath the retinal pigment epithelium with an irregular
shape, that cannot be classified as PED. SHM might be
due to scar tissue, blood or neovascular material.
Intraclass correlation coefficients (ICC) were sep-
arately calculated to assess inter-observer agreement
for grading morphologic pathologies within StratusTM
OCT (ICCStratusTM; data of FMS and CHS gradings),
and within SpectralisTM OCT (ICCSpectralisTM; data of
VS and RLS gradings). Calculating ICC is a statistical
procedure to determine the reproducibility (in this case
inter-observer agreement) of a measurement of a
variable. This correlation is based on variance compo-
nents analysis and measures the homogeneity within
groups relative to the total variation. The ICC is large
when there is little variation within the groups com-
pared to variation among group means. A small ICC
occurs when within-group variation is large compared
with between-group variability, indicating that some
unknown variable has introduced non-random effects
in the different groups. A linear mixed-effect model
was used to calculate variance components and 95 %
confidence intervals (95 % CI) for eyes, OCT devices,
Fig. 1 Four different OCT
scan types used in a left eye
with neovascular age-
related macular
degeneration. On the left,
different scan patterns are
projected on either infrared
fundus images (StratusTM
OCT) or scanning laser
ophthalmoscope fundus
images (SpectralisTM OCT).
All presented B-scan images
on the right were performed
in horizontal direction and
focused on the fovea. Top
fast macular scan pattern
(StratusTM OCT). Second
from top Cross hair scan
pattern (StratusTM OCT).
Third from top: Volume
scan pattern (SpectralisTM
OCT). Bottom Radial line
scan pattern (SpectralisTM
OCT). In all B-scan images
one can appreciate two
retinal pigment epithelium
detachments and subretinal
fluid accumulation
Int Ophthalmol (2013) 33:47–52 49
123
and scan types. Commercial software (Stata, ver. 9.2;
StataCorp, College Station, TX) was used for analysis.
Results
The mean age of the study subjects was 78 ± 6 years,
with a range of 42–88 years. Eighteen patients were
female. Good quality OCT scans could be performed
in all 30 eyes with StratusTM OCT (FMS and CHS)
and SpectralisTM OCT (VS and RLS). Table 1 shows
variance components with 95 % confidence intervals
for eyes, OCT device, scan type, and the correspond-
ing ICCs for the agreement of OCT image grading. In
StratusTM OCT the highest agreement was found for
SRF (ICCStratusTM: 0.79). In Spectralis
TM OCT the
highest ICC was found for identification of IRC
(ICCSpectralisTM: 0.93). Lowest agreement was found
for SHM with an ICCStratusTM of 0.65, and an
ICCSpectralisTM of 0.52. Spectralis
TM OCT showed
marked superior inter-observer agreement for IRC
and ERM compared to StratusTM OCT.
Discussion
In our study, SpectralisTM OCT showed superior inter-
observer agreement for grading IRC and ERM. This
suggests that increased image resolution might be
beneficial for grading pathologies that are located in
the vitreo-retinal interface or in the neurosensory
retina. In addition, the increased retinal coverage
increased the chance of finding pathologies. This might
also explain the better agreement. The used SD-OCT
device was operated with 25 line scans for each raster
scan although it is capable of performing more line
scans if necessary. Other SD-OCT models use raster
scans with up to 128 line-scans which increases retinal
coverage even more. Interestingly, the improved
image resolution and scan coverage of SD-OCT did
not significantly improve inter-observer OCT image
grading agreement for most other pathologies tested.
Lowest inter-observer agreement was found for
SHM. It seems to be difficult to distinguish SHM from
other pigment epithelial changes, intraretinal blood, or
increased light penetration artifacts due to pigment
epithelium atrophy. These findings are in agreement
with previous studies of Zhang et al. [26] who tested
OCT reader agreement in neovascular AMD by
comparing 3 observers, who were certified by an
OCT reading center. All observers used a standardized
grading protocol. Two different scan protocols (FMS
and 7 mm line scan) were compared and all scans were
performed with the StratusTM OCT. Inter-observer
agreement was found to be high for 7 of 8 pathologies
tested (IRC, SRF, ERM, PED, macular edema, vitre-
omacular interface changes, choroidal neovasculari-
sations) ranging from 79 to 98 %. Observer agreement
for pigment epithelium atrophy was significantly lower
and ranged from 43 to 50 %. No significant differences
were found between the two tested scan types.
Recently, Sayanagi et al. [37] compared 4 different
SD-OCT models versus TD-OCT for the management
of neovascular AMD. In their study, inter-observer
reproducibility for OCT image grading was not tested,
but they found all 4 SD-OCT models to be superior in
detecting SRF, IRC, intraretinal fluid and sub-RPE
fluid compared to TD-OCT. In contrast, our results
Table 1 Inter-observer agreement of OCT image grading for different pathologies
Var. eye 95 % CI Var. OCT type 95 % CI Var. scantype 95 % CI ICC Stratus
TM
ICC Spectralis
TM
IRC 9.68 4.1–22 1.93 0.46–7.98 0.98 0.15–6.39 0.61 0.93
SRF 7.07 2.64–18.9 3.91 1.38–11.13 5.46e-14 0 0.79 0.73
PED 5.2 2.21–12.26 0.91 0.2–4.19 2.57e-14 0 0.66 0.66
ERM 6.24 1.98–19.68 2.31 0.46–11.68 0.78 0.05–13.35 0.56 0.84
SHM 3.77 1.87–7.61 0.27 0.02–4.41 3.80e-22 0 0.65 0.52
Intraclass correlation coefficient (ICC) values are presented for StratusTM OCT, and SpectralisTM OCT inter-observer agreement
The linear mixed model was used to calculate ICCs. ICC StratusTM = Inter-observer agreement of StratusTM OCT image grading in
regard of given pathology
ICC SpectralisTM = Inter-observer agreement of SpectralisTM OCT image grading in regard of given pathology
Var. variance; CI confidence interval; IRC intra-retinal cyst; SRF sub-retinal fluid; PED pigment epithelium detachment; ERM
epiretinal membrane; SHM subretinal hyper-reflective material
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showed no differences between OCT types in grading
PED and SRF. One can hypothesize that image
resolution of TD-OCT seems to be sufficient to
identify all PED and SRF if present in line scans.
Although the previously published data indicates a
relatively good inter-observer agreement in OCT
reading centers, one has to be cautious in assuming
the same inter-observer agreement in daily clinical
routine [26]. Usually, treating physicians are not
trained by an OCT reading center and personal clinical
experience is applied when deciding on re-treatment
rather than a standardized OCT grading protocol. In
larger clinics, the same patient is often treated by
various ophthalmologists. Therefore, inter-observer
variability in OCT image grading might even lead to
changing treatment protocols in patients with neovas-
cular AMD. In this study, observers were experienced
OCT user but not specifically trained by an OCT
reading center. This might explain the lower inter-
observer agreement compared to previously published
data [26].
Previously, automated quantitative subanalysis of
morphologic pathologies such as PEDs and SRF has
been introduced for computer assisted image grading
[24, 38]. Such software systems are however not
common and are mostly used for quantitative analysis.
Our data indicates that most pathologies can be graded
with good inter-observer agreement regardless of the
used OCT device without automated sub-analysis
tools. However, agreement was poor for grading SHM
in both OCT devices. To our knowledge, no automated
sub-analysis tool is available for identification and
quantification of SHM. Since subretinal hemorrhages,
choroidal neovascularisations and subretinal scar
tissue appears very similar in OCT, further diagnostics
will be needed to differentiate these conditions from
each other.
In conclusion, our study showed relatively good
inter-observer agreement for most tested pathologies
for both OCT devices, except for SHM. SpectralisTM
OCT showed superior inter-observer agreement for
IRC and ERM. This indicates that increased image
resolution of SD-OCT might show structural abnor-
malities located in the vitreo-retinal interface or in the
neurosensory retina more accurately, which facilitates
image grading for these morphologic changes.
Ethical standard The study was performed with informed
consent and followed all the guidelines for experimental
investigations required by the Ethics Committee of the
University of Zurich which approved this study.
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